// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
Before COVID-19, most people might vaguely remember messenger RNA (mRNA) from a high school biolo
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis